Diclazuril reaches therapeutic levels within 12 hours, reinforcing the drug as a first-line EPM treatment option RAHWAY, N.J., September 24, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the results of a new […]
Expert tips for preventing spring respiratory disease outbreaks RAHWAY, N.J., February 11, 2025 – As winter transitions to spring, horse owners and barn managers should be on alert for equine influenza (EIV), a highly contagious respiratory disease that has historically surged during this time of year (see figure 1). Recent biosurveillance data underscores this seasonal […]
Equine-specific campaign highlights the critical importance of rabies vaccination to protect horses and the people who care for them RAHWAY, N.J., September 27, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), is proud to announce […]
New scanning technology enhances Standardbred industry’s pioneering approach to equine identification and monitoring RAHWAY, N.J., June 18, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), is pleased to recognize a 50,000-microchip milestone as part of […]